United States · FDA National Drug Code directory
OZEMPIC
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-1715_6834044a-22f1-4f35-b846-b3448ee84c16
- Product NDC
- 0169-1715
- Form
- TABLET
- Composition / generic term
- oral semaglutide
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260427
- Source listing expiry
- 20271231
Source-listed ingredients
- SEMAGLUTIDE — 1.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (0169-1715-30) · 0169-1715-30
- 30 TABLET in 1 BOTTLE, PLASTIC (0169-1715-90) · 0169-1715-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →